Published in Hepatitis Weekly, May 10th, 2010
"The objective of this study was to determine whether retroviral vectors can deliver the HDV ribozyme into the target cells...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.